Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Liou TH
------>authors3_c=
------>paper_class1=1
------>Impact_Factor=1.015
------>paper_class3=2
------>paper_class2=1
------>vol=16
------>confirm_bywho=shtsai
------>insert_bywho=peter_liou
------>Jurnal_Rank=66.0
------>authors4_c=
------>comm_author=
------>patent_EDate=None
------>authors5_c=
------>publish_day=1
------>paper_class2Letter=None
------>page2=586
------>medlineContent=
------>unit=J0600
------>insert_date=20071205
------>iam=1
------>update_date=None
------>author=???
------>change_event=4
------>ISSN=
------>authors_c=
------>score=500
------>journal_name=Asia Pac J Clin Nutr
------>paper_name=Anti-obesity drug use before professional treatment in Taiwan
------>confirm_date=20071213
------>tch_id=093035
------>pmid=17704041
------>page1=580
------>fullAbstract=Between July 2004 and June 2005, a cross-sectional study was performed to determine the prevalence and patterns of anti-obesity medicine use among subjects seeking obesity treatment in Taiwan. Eighteen obesity outpatient clinics were selected via a random stratified sampling method and 1,060 first-visit clients (791 females and 269 males) aged above 18 years were enrolled and then completed a self-administered questionnaire. The prevalence of anti-obesity medicine use was 50.8%; more females than male used anti-obesity medicines (53.6% vs. 42.4%). Of the 1,060 subjects, 17.1% had used orlistat, 21.1% had taken sibutramine, and 18.3% had utilized un-proven drugs such as cocktail therapy and other anti-obesity drugs. Furthermore, 23.6% and 22.4% of subjects indicated that they concurrently used Chinese herbal preparations and dietary supplements, respectively. Logistic regression analyses demonstrated that the odds ratio (OR) for anti-obesity medicine use was substantially higher in females (OR, 1.9; 95% CI, 1.3-2.6), those aged 18-24 years (OR, 1.6; 95% CI, 1.0-2.6), those with a body mass index (BMI) >35 kg/m2 (OR, 3.4; 95% CI, 2.1-5.7) and respondents concurrently using Chinese herbal preparations (OR, 1.7; 95% CI, 1.2-2.4) and dietary supplements (OR, 2.2; 95% CI, 1.6-3.1). In conclusion, the prevalence of anti-obesity drugs use is high among Taiwanese adults before they seek obesity treatment. Young, obese females, and those who had taken Chinese herbal preparations/dietary supplements had a high likelihood to report using anti-obesity medicines. Use of unproven weight-loss drugs is common and warrants further investigation.
------>tmu_sno=None
------>sno=16363
------>authors2=Wu CH
------>authors3=Chien HC
------>authors4=Lin WY
------>authors5=Lee WJ
------>authors6=Chou P
------>authors6_c=
------>authors=Liou TH
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=
------>publish_area=0
------>updateTitle=Anti-obesity drug use before professional treatment in Taiwan.
------>language=2
------>check_flag=None
------>submit_date=None
------>country=None
------>no=3
------>patent_SDate=None
------>update_bywho=None
------>publish_year=2007
------>submit_flag=None
------>publish_month=5
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z